Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Shroff · SciRah

Researcher profile · Semantic Scholar

R. Shroff

Share profile

R. Shroff — researcher profile on SciRah

h-index: 47
Works: 228
Citations: 12K

Most-cited papers

Pancreatic cancer
J. Mizrahi, R. Surana, J. Valle, R. Shroff
2020The Lancet959 citations
Semantic Scholar
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
G. Abou-Alfa, T. Macarulla, M. Javle, R. Kelley +22 more
2020The Lancet Oncology857 citations Open access
Semantic Scholar
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation
A. Zhu, T. Macarulla, M. Javle, R. Kelley +23 more
2021JAMA Oncology460 citations Open access
Semantic Scholar
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.
R. Shroff, E. Kennedy, M. Bachini, T. Bekaii-Saab +9 more
2019Journal of Clinical Oncology371 citations Open access
Semantic Scholar
AASLD Practice Guidance on Primary Sclerosing Cholangitis and Cholangiocarcinoma.
C. Bowlus, L. Arrivé, A. Bergquist, M. Deneau +8 more
2022Hepatology366 citations Open access
Semantic Scholar
Immune Responses to Two and Three Doses of the BNT162b2 mRNA Vaccine in Adults with Solid Tumors
R. Shroff, P. Chalasani, R. Wei, Daniel Pennington +18 more
2021Nature Medicine201 citations Open access
Semantic Scholar
Current and emerging therapies for advanced biliary tract cancers.
A. Kam, A. Masood, R. Shroff
2021The Lancet Gastroenterology and Hepatology147 citations
Semantic Scholar
The Clinical Landscape of Cell-Free DNA Alterations in 1,671 Patients with Advanced Biliary Tract Cancer.
J. Berchuck, F. Facchinetti, D. Ditoro, I. Baiev +25 more
2022Annals of Oncology135 citations Open access
Semantic Scholar
Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma
Loryn Holokai, J. Chakrabarti, Joanne Lundy, Daniel Croagh +14 more
2020Cancers100 citations Open access
Semantic Scholar
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial.
S. Makawita, G. Abou-Alfa, S. Roychowdhury, S. Sadeghi +12 more
2020Future Oncology90 citations Open access
Semantic Scholar
SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.
R. Shroff, K. Guthrie, A. Scott, M. Borad +16 more
2023Journal of Clinical Oncology80 citations Open access
Semantic Scholar
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures
K. Mody, Prerna Jain, S. El-Refai, N. Azad +9 more
2022JCO Precision Oncology59 citations Open access
Semantic Scholar
The Immunogenomic Landscape of Resected Intrahepatic Cholangiocarcinoma
F. Carapeto, Behnaz Bozorgui, R. Shroff, Sharmeen Chagani +8 more
2021Hepatology58 citations Open access
Semantic Scholar
Precision Medicine in Biliary Tract Cancer.
A. Scott, R. Sharman, R. Shroff
2022Journal of Clinical Oncology55 citations
Semantic Scholar
Cholangiocarcinoma: a review of the literature and future directions in therapy
Ritika Halder, A. Amaraneni, R. Shroff
2021Hepatobiliary surgery and nutrition48 citations Open access
Semantic Scholar
Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015
J. Koshiol, Bin-Bing Yu, Shaum M. Kabadi, K. Baria +1 more
2022BMC Cancer44 citations Open access
Semantic Scholar
Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis
A. Mai, Ainsley Ryan Yan Bin Lee, R. Tay, Lauren C. Shapiro +16 more
2022European Journal of Cancer44 citations Open access
Semantic Scholar
A phase III study of futibatinib (TAS-120) versus gemcitabine-cisplatin (gem-cis) chemotherapy as first-line (1L) treatment for patients (pts) with advanced (adv) cholangiocarcinoma (CCA) harboring fibroblast growth factor receptor 2 (FGFR2) gene rearrangements (FOENIX-CCA3).
M. Borad, J. Bridgewater, C. Morizane, R. Shroff +6 more
202040 citations
Semantic Scholar
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer
J. Goldstein, Li Zhao, Xue-Mei Wang, Yael Ghelman +8 more
2019Clinical Cancer Research38 citations Open access
Semantic Scholar
Modified FOLFIRINOX in Pancreatic Cancer Patients Age 75 or Older
J. Mizrahi, J. Rogers, K. Hess, R. Wolff +8 more
2020Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]37 citations Open access
Semantic Scholar
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy
R. Shroff, P. Chalasani, R. Wei, Daniel Pennington +18 more
2021medRxiv34 citations Open access
Semantic Scholar
New Treatment Options for Advanced Biliary Tract Cancer
J. Mizrahi, R. Shroff
2020Current Treatment Options in Oncology34 citations
Semantic Scholar
Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase Inhibitors
Morten Lapin, Helen J. Huang, Sharmeen Chagani, M. Javle +13 more
2022JCO Precision Oncology30 citations Open access
Semantic Scholar
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma
K. Spencer, Leontios Pappas, I. Baiev, J. Maurer +26 more
2023Journal of the National Cancer Institute29 citations Open access
Semantic Scholar
525O A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies
G. Ku, J. Bendell, A. Tolcher, S. Hurvitz +14 more
2020Annals of Oncology29 citations Open access
Semantic Scholar
O82 A phase 1 dose escalation study of PRS-343, a HER2/4–1BB bispecific molecule, in patients with HER2-positive malignancies
S. Piha-Paul, J. Bendell, A. Tolcher, S. Hurvitz +14 more
2020Journal of Immunotherapy for Cancer28 citations Open access
Semantic Scholar
Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer
E. Koay, M. Katz, Hua-Min Wang, Xue-Mei Wang +20 more
2019JCO Precision Oncology25 citations Open access
Semantic Scholar
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated by Gemcitabine-based Chemotherapy.
Sunyoung S. Lee, R. Shroff, S. Makawita, Lianchun Xiao +8 more
2022Clinical Cancer Research21 citations Open access
Semantic Scholar
Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC)Unveils New Actionable Genomic Aberrations in PACC.
V. Florou, A. Elliott, M. Bailey, David E Stone +10 more
2023Clinical Cancer Research20 citations Open access
Semantic Scholar
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
L. Pappas, I. Baiev, Stephanie Reyes, A. Bocobo +27 more
2023JCO Precision Oncology20 citations Open access
Semantic Scholar
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
J. Mizrahi, Valerie Gunchick, K. Mody, Lianchun Xiao +3 more
2020World Journal of Gastrointestinal Oncology20 citations Open access
Semantic Scholar
KRASG12D-Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients
V. LeBleu, B. Smaglo, K. Mahadevan, M. Kirtley +20 more
2025medRxiv19 citations Open access
Semantic Scholar
Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer
I. Ogobuiro, Y. Baca, Jennifer R. Ribeiro, P. Walker +15 more
2023JCO Precision Oncology19 citations Open access
Semantic Scholar
Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease
L. Vrba, B. Futscher, M. Oshiro, G. Watts +9 more
2022Clinical Epigenetics19 citations Open access
Semantic Scholar
Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review.
Nishant Munugala, S. Maithel, R. Shroff
2020Hepatobiliary surgery and nutrition19 citations Open access
Semantic Scholar
Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism
Alejandro Recio-Boiles, S. Veeravelli, Jessica Vondrak, H. Babiker +5 more
2019World Journal of Gastrointestinal Oncology19 citations Open access
Semantic Scholar
A phase I study of LY3410738, a first-in-class covalent inhibitor of mutant IDH1 in cholangiocarcinoma and other advanced solid tumors.
J. Pauff, K. Papadopoulos, F. Janku, A. Turk +16 more
202115 citations
Semantic Scholar
PROOF 301: Results of an early discontinued randomized phase 3 trial of the oral FGFR inhibitor infigratinib vs. gemcitabine plus cisplatin in patients with advanced cholangiocarcinoma (CCA) with an FGFR2 gene fusion/rearrangement.
G. Abou-Alfa, I. Borbath, S. Roychowdhury, L. Goyal +11 more
2024Journal of Clinical Oncology11 citations
Semantic Scholar
Abstract CT098: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced IDH-mutant cholangiocarcinoma and other solid tumors
J. Rodón, L. Goyal, T. M. Mercade, M. Ikeda +31 more
2023Cancer Research11 citations
Semantic Scholar
PROOF 301: A multicenter, open-label, randomized, phase 3 trial of infigratinib versus gemcitabine plus cisplatin in patients with advanced cholangiocarcinoma with an FGFR2 gene fusion/rearrangement.
G. Abou-Alfa, I. Borbath, L. Goyal, A. Lamarca +10 more
2022Journal of Clinical Oncology10 citations
Semantic Scholar
The impact of molecular profiling on cholangiocarcinoma clinical trials and experimental drugs
Q. R. Sipra, R. Shroff
2020Expert Opinion on Investigational Drugs10 citations Open access
Semantic Scholar
Biliary tract cancers: systemic therapy for advanced disease.
F. J. Martínez, R. Shroff
2019Chinese Clinical Oncology10 citations Open access
Semantic Scholar
Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
J. Rogers, J. Mizrahi, Lianchun Xiao, C. Mohindroo +9 more
2020Cancer Medicine9 citations Open access
Semantic Scholar
Not all treated KRAS-mutant pancreatic adenocarcinomas are equal: KRAS G12D and survival outcome.
B. Ardalan, Aaron T. Ciner, Y. Baca, S. Darabi +11 more
2023Journal of Clinical Oncology8 citations Open access
Semantic Scholar
The Room Where It Happens: Addressing Diversity, Equity, and Inclusion in NCTN Clinical Trial Leadership.
R. Snyder, B. Burtness, M. Cho, J. del Rivero +13 more
2023Journal of the National Cancer Institute7 citations Open access
Semantic Scholar
Natural history of patients (pts) with advanced cholangiocarcinoma (CCA) with FGFR2 gene fusion/rearrangement or wild-type (WT) FGFR2.
R. Shroff, J. Rearden, Ai Li, S. Moran +2 more
20217 citations
Semantic Scholar
Moving the Needle Forward With Locoregional Treatment in Unresectable Cholangiocarcinoma-The Jury Is Still Out.
A. Scott, R. Shroff
2019JAMA Oncology7 citations
Semantic Scholar
COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC
N. Azad, Z. Hu, I. Sahin, R. Iyer +21 more
2024Future Oncology6 citations Open access
Semantic Scholar
Treatment options for biliary tract cancer: unmet needs, new targets and opportunities from both physicians' and patients' perspectives
R. Shroff, M. Bachini
2024Future Oncology5 citations Open access
Semantic Scholar
Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemia.
J. Rogers, J. Mizrahi, R. Shroff, D. Nelson +4 more
2020Journal of Gastrointestinal Oncology5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Javle×18
Invite
M. Javle — researcher profile on SciRah
M. Borad×10
Invite
M. Borad — researcher profile on SciRah
L. Goyal×10
Invite
L. Goyal — researcher profile on SciRah
A. El-Khoueiry×7
Invite
A. El-Khoueiry — researcher profile on SciRah

×6

Invite

J. Mizrahi — researcher profile on SciRah

Invite

D. Oh — researcher profile on SciRah

Invite

A. Scott — researcher profile on SciRah

Invite

R. Wolff — researcher profile on SciRah

Invite

J. Valle — researcher profile on SciRah

G. Abou-Alfa×5

Invite

G. Abou-Alfa — researcher profile on SciRah

T. Macarulla×5

Invite

T. Macarulla — researcher profile on SciRah

Invite

R. Kelley — researcher profile on SciRah